Skip to main content
Log in

Suppression of cyclooxygenase-2 expression induced by Toll-like receptor 2 or 4 agonists by (E)-isopropyl 4-oxo-4-(2-oxopyrrolidin-1-yl)-2-butenoate

  • Original Paper
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Inflammation can be initiated by invading microbial pathogens. Toll-like receptors (TLRs) recognize molecular structures derived from microbial pathogens and regulate the activation of innate immunity. TLR signaling pathways trigger the activation of nuclear factor-κB(NF-κB) transcription factor, leading to the induction of inflammatory gene products such as cyclooxygenase-2. Here, we present biochemical evidence that the fumaryl pyrrolidinone, (E)-isopropyl 4-oxo-4-(2-oxopyrrolidin-1-yl)-2-butenoate (IPOP), previously synthesized in our laboratory inhibits NF-κB activation induced by TLR agonists and overexpression of two downstream signaling components of TLRs. IPOP also inhibits TLR agonist-induced expression of cyclooxygenase-2. Our results suggest that IPOP can modulate TLR-mediated inflammatory responses and, potentially, the risk of many chronic inflammatory diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int Immunol 17:1–14 (2005).

    Article  PubMed  CAS  Google Scholar 

  2. Fritz, J. H. & Girardin, S. E. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res 11:390–394 (2005).

    PubMed  CAS  Google Scholar 

  3. Medzhitov, R. Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145 (2001).

    Article  PubMed  CAS  Google Scholar 

  4. Vogel, S. N., Fitzgerald, K. A. & Fenton, M. J. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 3:466–477 (2003).

    Article  PubMed  CAS  Google Scholar 

  5. Ospelt, C. & Gay, S. TLRs and chronic inflammation. Int J Biochem Cell Biol 42:495–505 (2009).

    Article  PubMed  Google Scholar 

  6. Heil, F. et al. Species-specific recognition of singlestranded RNA via toll-like receptor 7 and 8. Science 303:1526–1529 (2004).

    Article  PubMed  CAS  Google Scholar 

  7. Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496 (2003).

    Article  PubMed  CAS  Google Scholar 

  8. Meylan, E. et al. RIP1 is an essential mediator of Tolllike receptor 3-induced NF-kappa B activation. Nat Immunol 5:503–507 (2004).

    Article  PubMed  CAS  Google Scholar 

  9. Yazdi, M. R. & Mrowietz, U. Fumaric acid esters. Clin Dermatol 26:522–526 (2008).

    Article  Google Scholar 

  10. Schweckendiek, W. Treatment of psoriasis vulgaris. Med Monatsschr 13:103–104 (1959).

    PubMed  CAS  Google Scholar 

  11. Evans, D. A., Scheidt, K. A., Johnston, J. N. & Willis, M. C. Enantioselective and diastereoselective Mukaiyama-Michael reactions catalyzed by bis (oxazoline) copper (II) complexes. J Am Chem Soc 123:4480–4491 (2001).

    Article  PubMed  CAS  Google Scholar 

  12. Kang, S. H., Kang, Y. K., & Kim, D. Y. Catalytic enantioselective conjugate addition of aromatic amines to fumarate derivatives: asymmetric synthesis of aspartic acid derivatives. Tetrahedron 65:5676–5679 (2009).

    Article  CAS  Google Scholar 

  13. Rhee, S. H. & Hwang, D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 275:34035–34040 (2000).

    Article  PubMed  CAS  Google Scholar 

  14. Chi, Z. L., Hayasaka, S., Zhang, X. Y., Hayasaka, Y. & Cui, H. S. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharideinduced uveitis in rats. Invest Ophthalmol Vis Sci 45:2497–2502 (2004).

    Article  PubMed  Google Scholar 

  15. Katsuyama, K. et al. N2733, 1-[3-(3-pyridyl)-acryloyl]-2-pyrrolidinone hydrochloride inhibits LPS-induced TNF-alpha production and improves survival in endotoxemic mice. Biosci Biotechnol Biochem 62:2177–2181 (1998).

    Article  PubMed  CAS  Google Scholar 

  16. Katsuyama, K. & Hirata, Y. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NFkappaB activation by preventing phosphorylation and degradation of IkappaB-alpha. J Biochem 129:585–591 (2001).

    PubMed  CAS  Google Scholar 

  17. Youn, H. S., Ahn, S. I. & Lee, B. Y. Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists. Int Immunopharmacol 9:108–112 (2009).

    Article  PubMed  CAS  Google Scholar 

  18. Ahn, S. I., Lee, J. K. & Youn, H. S. Inhibition of homodimerization of toll-like receptor 4 by 6-shogaol. Mol Cells 27:211–215 (2009).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyung-Sun Youn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, AN., Park, SJ., Koh, K.O. et al. Suppression of cyclooxygenase-2 expression induced by Toll-like receptor 2 or 4 agonists by (E)-isopropyl 4-oxo-4-(2-oxopyrrolidin-1-yl)-2-butenoate. Mol. Cell. Toxicol. 7, 39–44 (2011). https://doi.org/10.1007/s13273-011-0006-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13273-011-0006-0

Keywords

Navigation